ICU sedation, delirium & recovery
Remimazolam versus propofol for sedation in mechanically ventilated intensive care unit (ICU) patients: A systematic review and meta-analysis of randomized controlled trials
Pooled result · Percentage of time within the target sedation rangeResult — go to the resultMD −0.45% 95% CI −2.46 to 1.55Authors' conclusion
Remimazolam probably results in little to no difference in sedation efficacy compared with propofol in mechanically ventilated ICU patients. However, uncertainty remains regarding clinical and safety outcomes. Larger multinational RCTs are warranted to clarify these effects.
Study context
- Population
- Mechanically ventilated ICU patients
- Participants
- 705 participants
- Comparison
- Remimazolam vs propofol
- Outcome
- Percentage of time within the target sedation range
Pooled result
As reported in the abstract
Percentage of time within the target sedation range
MD
−0.45%
95% CI −2.46 to 1.55
P = 0.56
Remimazolamvs Propofol
MD −0.45% (95% CI −2.46 to 1.55); P = 0.56
Secondary outcomes
Sedation success rate, 28-day mortality, ICU mortality, ICU length of stay, and duration of mechanical ventilation
- No significant differences were detected
- Several estimates were imprecise
Safety
Safety outcomes (adverse events leading to dose reduction, hypotension, and delirium)
- No significant differences were detected
- Several estimates were imprecise
Original publication
Remimazolam versus propofol for sedation in mechanically ventilated ICU patients: A systematic review and meta-analysis of randomized controlled trials. J Crit Care. Published 4 November 2026. doi:10. 1016/ j. jcrc. 2026. 155798
Composed by AI from the published abstract and checked against it. How Briefs are made →